Labormed grows 30% in Q1

Generic drugs producer Labormed Pharma Bucharest has reported an increase in turnover of approximately 30% for the first quarter of the year compared the corresponding period last year. “Sales are increasing as anticipated in the budget earlier this year, chiefly as a result of cardiovascular drugs,” said Gabriel Cernica, the company”s marketing manager. Last year”s sales reached approximately 11 million euros. The company intends to launch two new products on the cardiovascular segment this year. They have a total of five drugs pending clearance for sale or for which clearance procedures will shortly be initiated, said Cernica. Sales on the cardiovascular segment performed better than the rest of the pharmaceutical market. Labormed has a portfolio of over 70 registered products in Romania, half of which are exported to Russia, Bulgaria and the countries of the Commonwealth of Independent States. ZF